CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...
Phase 2
Jacksonville, Florida, United States and 20 other locations
Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...
Phase 3
Jacksonville, Florida, United States and 202 other locations
cells (FRaDCs) plus pembrolizumab in patients with advanced ovarian, fallopian tube, or primary peritoneal cancer. Vaccines made fr...
Phase 1, Phase 2
Jacksonville, Florida, United States and 2 other locations
This study aims to assess efficacy of Niraparib (GSK3985771) as maintenance treatment in participants with Stage III or IV ovarian cancer...
Phase 3
Jacksonville, Florida, United States and 196 other locations
in patients with ROR1+ relapsed or refractory triple negative breast cancer (TNBC), non-small cell lung cancer (NSCLC), platinum-re ...
Phase 1
Jacksonville, Florida, United States and 17 other locations
following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...
Phase 3
Jacksonville, Florida, United States and 237 other locations
The goal of this study is to test A2B694, an autologous logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorec ...
Phase 1, Phase 2
Jacksonville, Florida, United States and 9 other locations
as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high fola...
Phase 3
Jacksonville, Florida, United States and 273 other locations
The purpose of the study is to test the safety of the medicine called SGN-B7H4V alone and with pembrolizumab in participants with solid tumors...
Phase 1
Jacksonville, Florida, United States and 18 other locations
open-label, single arm phase I study evaluating the safety and tolerability as well as some activity parameters of TG4050 in patients with ovarian...
Phase 1
Jacksonville, Florida, United States and 5 other locations
Clinical trials
Research sites
Resources
Legal